DENVER - DaVita Inc . (NYSE: NYSE:DVA), a prominent kidney care services provider, has appointed Jessica Hergenreter as its new Chief People Officer (CPO), effective today. Hergenreter will helm the People Services team, focusing on strategies to engage and support DaVita's global workforce of over 70,000 employees.
Prior to her new role at DaVita, Hergenreter garnered extensive experience at Vail Resorts (NYSE:MTN), where she held various leadership positions including Chief of Staff to the CEO and led talent strategies for a workforce of 55,000. Her background also includes HR consulting across diverse industries, adding to her broad expertise.
Javier Rodriguez, CEO of DaVita, emphasized the critical role of the company's employees in delivering patient care and expressed confidence in Hergenreter's ability to attract and retain top talent, as well as to uphold DaVita's reputation as an employer of choice.
Hergenreter, who has spent decades in Denver, expressed her admiration for DaVita's culture and her commitment to fostering an inclusive workplace that values diversity and belonging.
DaVita, which operates 3,124 outpatient dialysis centers worldwide, has been recognized for its clinical quality and innovation in kidney care over the past 20 years. The company's efforts have contributed to reduced hospitalizations and improved mortality rates, setting high standards of equitable and quality care for patients globally.
This leadership change is part of DaVita's ongoing efforts to enhance its organizational structure and continue providing high-quality care to its patients. The information is based on a press release statement from DaVita.
In other recent news, DaVita Inc. has announced several significant developments. The company has appointed David P. Maughan as the new Chief Operating Officer of DaVita Kidney Care, succeeding Michael D. Staffieri. Maughan's new role comes with an annual base salary of $725,000 and eligibility for a target incentive bonus equal to 100% of his base salary for 2024.
In financial news, DaVita outperformed Q2 2024 expectations with an adjusted operating income of $506 million and adjusted earnings per share of $2.59. The company's Board also approved an additional $2 billion authorization for its existing share repurchase program.
Truist Securities revised its earnings estimates for DaVita upward, now projecting the company to achieve an adjusted earnings per share of $9.72 in 2024, up from the previous estimate of $9.46. For 2025, the forecast has been raised to an adjusted EPS of $11.06, compared to the earlier prediction of $10.42. These recent developments highlight DaVita's ongoing strategic and financial progress.
InvestingPro Insights
DaVita Inc.'s recent appointment of Jessica Hergenreter as Chief People Officer aligns with the company's strong market position and financial performance. According to InvestingPro data, DaVita boasts a market capitalization of $13.59 billion, reflecting its significant presence in the healthcare sector. The company's revenue growth of 6.69% over the last twelve months as of Q2 2024 indicates steady expansion, which could be further bolstered by strategic talent management under Hergenreter's leadership.
InvestingPro Tips highlight DaVita's financial strength and market performance. The company is trading near its 52-week high, with a remarkable 115.79% price total return over the past year. This upward trajectory suggests investor confidence in DaVita's business model and growth prospects. Additionally, the company's price-to-earnings ratio of 16.77 is relatively low compared to its near-term earnings growth, indicating potential undervaluation.
DaVita's focus on employee engagement and retention, as emphasized in Hergenreter's appointment, is crucial for maintaining its operational excellence. This is particularly important given that DaVita does not pay dividends to shareholders, relying instead on stock appreciation and business growth to deliver value to investors.
For readers interested in a deeper analysis, InvestingPro offers 14 additional tips for DaVita, providing a comprehensive view of the company's financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.